Oxidative stress-induced 1, N6-ethenodeoxyadenosine adduct formation contributes to hepatocarcinogenesis

Oncology Reports

Volumn 29, Issue 3, 2013, Pages 875-884

  Zhou, Lei ^a,b   Yang, Yuzhen ^a   Tian, Dean ^a   Wang, Ying ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CENTRAL HOSPITAL OF WUHAN   (China)

Author keywords

1,N6 ethenodeoxyadenosine; Hepatocarcinogenesiss; Oxidative stress; P53

Indexed keywords

1,N6 ETHENODEOXYADENOSINE; ADENOSINE DERIVATIVE; CYCLINE; GLUTATHIONE; PROTEIN P53; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL NUCLEUS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ADDUCT; ENZYME ACTIVITY; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER FIBROSIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTINS; ADULT; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL NUCLEUS; DEOXYADENOSINES; DNA ADDUCTS; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROLIFERATING CELL NUCLEAR ANTIGEN; SUPEROXIDE DISMUTASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84872762189     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2227     Document Type: Article

References (37)

1. El-Serag HB and Rudolph KL: Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132: 2557-2576, 2007. (Pubitemid 46890874)
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
3. Donato F, Boffetta P and Puoti M: A meta-analysis of epidemio-logical studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75: 347-354, 1998. (Pubitemid 28100034)
4. Seitz HK and Stickel F: Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem 387: 349-360, 2006.
5. Severi T, Ying C, Vermeesch JR, Cassiman D, Cnops L, Verslype C, Fevery J, Arckens L, Neyts J and van Pelt JF: Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells. Mol Cell Biochem 290: 79-85, 2006. (Pubitemid 44473237)
6. Hsieh YH, Su IJ, Wang HC, Chang WW, Lei HY, Lai MD, Chang WT and Huang W: Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 25: 2023-2032, 2004. (Pubitemid 39405923)
7. Qadri I, Iwahashi M, Capasso JM, Hopken MW, Flores S, Schaack J and Simon FR: Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. Biochem J 378: 919-928, 2004. (Pubitemid 38406869)
8. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Miyazawa T, Ishiba shi K, Horie T, Imai K, Todoroki T, Kimura S and Koike K: Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61: 4365-4370, 2001. (Pubitemid 32685760)
9. Wang Y, Millonig G, Nair J, Patsenker E, Stickel F, Mueller S, Bartsch H and Seitz HK: Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology 50: 453-461, 2009.
10. Wu HC, Wang Q, Wang LW, Yang HI, Ahsan H, Tsai WY, Wang LY, Chen SY, Chen CJ and Santella RM: Urinary 8-oxode-oxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Carcinogenesis 28: 995-999, 2007. (Pubitemid 47072183)
11. Starley BQ, Calcagno CJ and Harrison SA: Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 51: 1820-1832, 2010.
12. Toyokuni S, Okamoto K, Yodoi J and Hiai H: Persistent oxidative stress in cancer. FEBS Lett 358: 1-3, 1995.
13. Bartsch H and Nair J: Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxi-dation, DNA damage, and repair. Langenbecks Arch Surg 391: 499-510, 2006. (Pubitemid 44337612)
14. 4-ethenocytosine by lipid peroxi-dation products and nucleic acid bases. Chem Res Toxicol 8: 278-283, 1995.
15. Barbin A, Froment O, Boivin S, Marion MJ, Belpoggi F, Maltoni C and Montesano R: p53 gene mutation pattern in rat liver tumors induced by vinyl chloride. Cancer Res 57: 1695-1698, 1997. (Pubitemid 27199661)
16. Horio Y, Chen A, Rice P, Roth JA, Malkinson AM and Schrump DS: Ki-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Mol Carcinog 17: 217-223, 1996. (Pubitemid 27050722)
17. Nair J, Carmichael PL, Fernando RC, Phillips DH, Strain AJ and Bartsch H: Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson's disease and primary hemochromatosis. Cancer Epidemiol Biomarkers Prev 7: 435-440, 1998. (Pubitemid 28354133)
18. 6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepatocar-cinogenesis. Carcinogenesis 25: 1027-1031, 2004. (Pubitemid 38898638)
19. Nair J, Srivatanakul P, Haas C, Jedpiyawongse A, Khuhaprema T, Seitz HK and Bartsch H: High urinary excretion of lipid peroxi-dation-derived DNA damage in patients with cancer-prone liver diseases. Mutat Res 683: 23-28, 2010.
20. Desmet VJ, Gerber M, Hoofnagle JH, Manns M and Scheuer PJ: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520, 1994. (Pubitemid 24166476)
21. Ichiba M, Maeta Y, Mukoyama T, Saeki T, Yasui S, Kanbe T, Okano J, Tanabe Y, Hirooka Y, Yamada S, Kurimasa A, Murawaki Y and Shiota G: Expression of 8-hydroxy-2'-deoxy-guanosine in chronic liver disease and hepatocellular carcinoma. Liver Int 23: 338-345, 2003. (Pubitemid 37259203)
22. Trachootham D, Alexandre J and Huang P: Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8: 579-591, 2009.
23. Bossi G, Lapi E, Strano S, Rinaldo C, Blandino G and Sacchi A: Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression. Oncogene 25: 304-309, 2006. (Pubitemid 43083692)
24. Shaulsky G, Goldfinger N and Rotter V: Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins. Cancer Res 51: 5232-5237, 1991.
25. Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H and Wakasa K: In situ detection of oxidative DNA damage, 8-hydroxydeoxyguano-sine, in chronic human liver disease. J Hepatol 35: 613-618, 2001. (Pubitemid 33078271)
26. Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell 140: 883-899, 2010.
27. Novo E and Parola M: Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 1: 5, 2008.
28. Bataller R, Schwabe R F, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ and Brenner DA: NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is cr itical in hepatic fibrosis. J Clin Invest 112: 1383-1394, 2003. (Pubitemid 38057692)
29. Bartsch H, Barbin A, Marion MJ, Nair J and Guichard Y: Formation, detection, and role in carcinogenesis of ethenobases in DNA. Drug Metab Rev 26: 349-371, 1994. (Pubitemid 24171638)
30. 4-ethenocytosine, and 4-amino-5-(imidazol-2-yl)imidazole. Biochemistry 32: 12793-12801, 1993. (Pubitemid 24005879)
31. 6-ethenodeoxyadenosine, a DNA adduct highly mutagenic in mammalian cells. Biochemistry 35: 11487-11492, 1996. (Pubitemid 26299323)
32. Palejwala VA, Rzepka RW, Simha D and Humayun MZ: Quantitative multiplex sequence analysis of mutational hot spots. Frequency and specificity of mutations induced by a site-specific ethenocytosine in M13 viral DNA. Biochemistry 32: 4105-4111, 1993. (Pubitemid 23127005)
33. Moriya M, Zhang W, Johnson F and Grollman AP: Mutagenic potency of exocyclic DNA adducts: marked differences between Escherichia coli and simian kidney cells. Proc Natl Acad Sci USA 91: 11899-11903, 1994. (Pubitemid 24368571)
34. 2, 3-ethenogua-nine produces G→A transitions in Escherichia coli. Proc Natl Acad Sci USA 88: 9974-9978, 1991. (Pubitemid 21915757)
35. 4-ethenocytosine, DNA reaction products of vinyl chloride metabolites, during in vitro DNA synthesis. Nucleic Acids Res 9: 375-387, 1981. (Pubitemid 11149713)
36. Miller JA and Miller EC: The metabolic activation and nucleic acid adducts of naturally-occurring carcinogens: recent results with ethyl carbamate and the spice flavors safrole and estragole. Br J Cancer 48: 1-15, 1983. (Pubitemid 13067940)
37. 6-ethenodeoxy-adenosine adduct in human cells. Cancer Res 60: 4098-4104, 2000. (Pubitemid 30636591)